These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 27383741)

  • 1. Early-stage clear cell tubulopapillary renal cell carcinoma: imaging features and distinction from clear cell and papillary subtypes.
    Mnatzakanian GN; Shinagare AB; Sahni VA; Hirsch MS; Silverman SG
    Abdom Radiol (NY); 2016 Nov; 41(11):2187-2195. PubMed ID: 27383741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
    Halefoglu AM; Ozagari AA
    Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
    Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
    Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clear Cell Papillary Renal Cell Carcinoma: A Recent Entity With Distinct Imaging Patterns.
    Tordjman M; Dbjay J; Chamouni A; Morini A; Timsit MO; Mejean A; Vasiliu V; Eiss D; Correas JM; Verkarre V; Helenon O
    AJR Am J Roentgenol; 2020 Mar; 214(3):579-587. PubMed ID: 31770020
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
    Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating papillary type I RCC from clear cell RCC and oncocytoma: application of whole-lesion volumetric ADC measurement.
    Paschall AK; Mirmomen SM; Symons R; Pourmorteza A; Gautam R; Sahai A; Dwyer AJ; Merino MJ; Metwalli AR; Linehan WM; Malayeri AA
    Abdom Radiol (NY); 2018 Sep; 43(9):2424-2430. PubMed ID: 29520425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT.
    Kim SH; Kim CS; Kim MJ; Cho JY; Cho SH
    AJR Am J Roentgenol; 2016 Jan; 206(1):W21-8. PubMed ID: 26700359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary vs clear cell renal cell carcinoma. Differentiation and grading by iodine concentration using DECT-correlation with microvascular density.
    Marcon J; Graser A; Horst D; Casuscelli J; Spek A; Stief CG; Reiser MF; Rübenthaler J; Buchner A; Staehler M
    Eur Radiol; 2020 Jan; 30(1):1-10. PubMed ID: 31278580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of renal cell carcinoma histological subtype and fuhrman grade using
    Nakajima R; Nozaki S; Kondo T; Nagashima Y; Abe K; Sakai S
    Eur Radiol; 2017 Nov; 27(11):4866-4873. PubMed ID: 28523353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodine quantification to distinguish clear cell from papillary renal cell carcinoma at dual-energy multidetector CT: a multireader diagnostic performance study.
    Mileto A; Marin D; Alfaro-Cordoba M; Ramirez-Giraldo JC; Eusemann CD; Scribano E; Blandino A; Mazziotti S; Ascenti G
    Radiology; 2014 Dec; 273(3):813-20. PubMed ID: 25162309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical imaging classification for the non-invasive differentiation of renal cell carcinoma into its main subtypes.
    Cupido BD; Sam M; Winters SD; Ahmed B; Seidler M; Huang G; Low G
    Abdom Radiol (NY); 2017 Mar; 42(3):908-917. PubMed ID: 27743018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging features of papillary renal cell carcinoma with cystic change-dominant appearance in the era of the 2016 WHO classification.
    Honda Y; Goto K; Nakamura Y; Terada H; Sentani K; Yasui W; Sekino Y; Hayashi T; Teishima J; Matsubara A; Fuji T; Kaichi Y; Higaki T; Baba Y; Iida M; Awai K
    Abdom Radiol (NY); 2017 Jul; 42(7):1850-1856. PubMed ID: 28534069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillary renal cell carcinoma and clear cell renal cell carcinoma: Differentiation of distinct histological types with contrast - enhanced ultrasonography.
    Xue LY; Lu Q; Huang BJ; Li Z; Li CX; Wen JX; Wang WP
    Eur J Radiol; 2015 Oct; 84(10):1849-56. PubMed ID: 26149528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
    Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
    AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
    Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histogram analysis of whole-lesion enhancement in differentiating clear cell from papillary subtype of renal cell cancer.
    Chandarana H; Rosenkrantz AB; Mussi TC; Kim S; Ahmad AA; Raj SD; McMenamy J; Melamed J; Babb JS; Kiefer B; Kiraly AP
    Radiology; 2012 Dec; 265(3):790-8. PubMed ID: 23175544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative iodine content threshold for discrimination of renal cell carcinomas using rapid kV-switching dual-energy CT.
    Zarzour JG; Milner D; Valentin R; Jackson BE; Gordetsky J; West J; Rais-Bahrami S; Morgan DE
    Abdom Radiol (NY); 2017 Mar; 42(3):727-734. PubMed ID: 27847998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid Renal Cell Carcinoma Measuring Water Attenuation (-10 to 20 HU) on Unenhanced CT.
    Schieda N; Vakili M; Dilauro M; Hodgdon T; Flood TA; Shabana WM
    AJR Am J Roentgenol; 2015 Dec; 205(6):1215-21. PubMed ID: 26587928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cortico-medullary phase contrast-enhanced MDCT and T2-weighted MR imaging in the histological subtype differentiation of renal cell carcinoma: radiology-pathology correlation.
    Halefoglu AM; Ozagari AA
    Pol J Radiol; 2021; 86():e583-e593. PubMed ID: 34876939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.